% 5

: Omr-igg-am 5 %. ?  »
|
-

I.V

Solution For Injection

Replacement therapy * PRIMARY immunodeficiency (patients with PRIMARY defective antibody synthesis such as agammaglobulinemia OR hypogammaglobulinemia) * Myeloma OR chronic Lymphocytic Leukemia (CLL) with severe secondary hypogammaglobulinemia AND recurrent infections. * Children with congenital AIDS AND recurrent infections - Immunomodulation * Idiopathic Thrombocytopenic Purpura (ITP) * Guillain Barre Syndrome * Kawasaki Disease - Allogenic Bone Marrow Transplantation

127 54 30698 00

Omrix Biopharmaceuticals Ltd

06/2013 - 06/2023

.
, .
.
/
Immunoglobulin normal human 5 G / 100 ML
Bottle glass type ii x 50 ML 24
Bottle glass type ii x 100 ML 24
Bottle glass type ii x 200 ML 24

*

*

 

.

...
 »
 
" !
 

? !
 »
278
"